Enhancement of P-gylcoprotein modulators of arylmethylamine-phenyl derivatives: An integrative modeling approach

Medicinal Chemistry Research

Volumn 22, Issue 5, 2013, Pages 2511-2523

  Madhavan, Thirumurthy ^a,b   Gadhe, Changdev G ^a   Kothandan, Gugan ^a   Cho, Seung Joo ^a  

^a Chosun University   (South Korea)

^b SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

CoMFA; CoMSIA; HQSAR; P gp

Indexed keywords

ARYLMETHYLAMINE PHENYL DERIVATIVE; BENZENE DERIVATIVE; GLYCOPROTEIN P INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS; HYDROGEN BOND; PREDICTIVE VALUE; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 84879684503     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-012-0246-0     Document Type: Article

References (33)

1. Bauer B, Hartz A, Fricker G, Miller DS (2005) Modulation of p-glycoprotein transport function at the blood-brain barrier. Exp Biol Med 230:118-127
2. Besler BH, Merz KM, Kollman PA (1990) Atomic charges derived from semiempirical methods. J Comp Chem 11:431-439
3. Boekhorst PAW, Kapel J, Schoester M, Sonneveld P (1992) Reversal of typical multidrug resistance by cyclosporin and its non-immunosuppressive analogue SDZ PSC 833 in Chinese hamster ovary cells expressing the mdr1 phenotype. Cancer Chemother Pharmacol 30:238-242
4. Clark RD, Fox PC (2004) Statistical variation in progressive scrambling. J Comput Aided Mol Des 18:563-576
5. Colabufo NA, Berardi F, Perrone R, Rapposelli S, Digiacomo M, Vanni M, Balsamo A (2008) Synthesis and biological evaluation of (hetero) arylmethyloxy- and arylmethylamine-phenyl derivatives as potent P-glycoprotein modulating agents. J Med Chem 51:1415-1422
6. Cornell WD, Cieplak P, Bayly CI, Kollmann PA (1993) Application of RESP charges to calculate conformational energies, hydrogen bond energies, and free energies of salvation. J Am Chem Soc 115:9620-9631
7. Cramer RD, Bunce JD, Patterson DE, Frank IE (1988) Crossvalidation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies. Quant Struct-Act Relat 7:18-25
8. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Klene M, Li X, Knox JE, Hratchian HP, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Ayala PY, Morokuma K, Voth GA, Salvador P, Dannenberg JJ, Zakrzewski VG, Dapprich S, Daniels AD, Strain MC, Farkas O, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Ortiz JV, Cui Q, Baboul AG, Clifford S, Cioslowski J, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Gonzalez C, Pople JA (2004) Gaussian Inc., Wallingford, CT
9. Gadhe CG, Lee SH, Madhavan T, Kothandan G, Choi DB, Cho SJ (2010) Ligand based CoMFA, CoMSIA and HQSAR analysis of CCR5 antagonists. Bull Korean Chem Soc 31:2761-2770
10. Gadhe CG, Madhavan T, Kothandan G, Cho SJ (2011) In silico quantitative structure-activity relationship studies on P-gp modulators of tetrahydroisoquinoline-ethyl-phenylamine series. BMC Struct Biol 5:1-15
11. Geladi P, Xie YL, Polissar A, Hopke P (1998) Regression on parameters from three way decomposition. J Chemom 12:337-354
12. Globisch C, Pajeva IK, Wiese M (2006) Structure-activity relationships of a series of tariquidar analogs as multidrug resistance modulators. Bioorg Med Chem 14:1588-1598
13. Golbraikh A, Tropsha A (2002) Beware of q2! J Mol Graph Model 20:269-276
14. Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2:48-58
15. Hurst T, Heritage T (1997) HQSAR - a highly predictive QSAR technique based on molecular holograms. In: 213th ACS National Meeting, San Francisco, CA, CINF 019
16. Jakalian A, Jack DB, Bayly CI (2002) Fast, efficient generation of high quality atomic charges. AM1 BCC model: II. Parameterization and validation. J Comput Chem 23:1623-1641
17. Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37:4130-4146
18. Kothandan G, Gadhe CG, Madhavan T, Choi CH, Cho SJ (2011) Docking and 3D-QSAR (quantitative structure activity relationship) studies of flavones, the potent inhibitors of p-glycoprotein targeting the nucleotide binding domain. Eur J Med Chem 46:4078-4088
19. Loscher W, Potschka H (2005) Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2:86-98
20. Madhavan T, Gadhe CG, Kothandan G, Lee K, Cho SJ (2011) Various atomic charge calculation schemes of CoMFA on HIF 1 inhibitors of moracin analogs. Int J Quant Chem. doi: 10.1002/qua.23084
21. Müller H, Pajeva IK, Globisch C, Wiese M (2008) Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors. Bioorg Med Chem 16:2448-2462
22. Pasha FA, Muddassar M, Srivastava AK, Cho SJ (2010) In silico QSAR studies of anilinoquinolines as EGFR inhibitors. J Mol Model 16:263-277
23. Robert J, Jarry C (2003) Multidrug resistance reversal agents. J Med Chem 46:4805-4817
24. Sarkadi B, Homolya L, Szakács G, Váradi A (2006) Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol Rev 86:1179-1236
25. Thomas H, Coley HM (2003) Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. Cancer Control 10:159-165
26. Tsai KC, Chen YC, Hsiao NW, Wang CL, Lin CL, Lee YC, Li M, Wang B (2010) A comparison of different electrostatic potentials on prediction accuracy in CoMFA and CoMSIA studies. Eur J Med Chem 45:1544-1551
27. Tsuruo T, Iida H, Yamashiro M, Tsukagoshi S, Sakurai Y (1982) Enhancement of vincristine-and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin. Biochem Pharmacol 31:3138-3140
28. Twentyman PR, Bleehen NM (1991) Resistance modification by PSC-833, a novel nonimmunosuppressive cyclosporin A. Eur J Cancer 27:1639-1642
29. Varma MVS, Ashokraj Y, Dey CS, Panchagnula R (2003) P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol Res 48:347-359
30. Viswanadhan VN, Ghose AK, Revankar GR, Robins RK (1989) Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics. J Chem Inf Comput Sci 29:163-172
31. Wold S (1978) Cross-validatory estimation of the number of components in factor and principal components models. Technometrics 20:397-405
32. Wold S, Ruhe A, Wold H, Dunn WJ (1984) The collinearity problem in linear regression. The partial least squares (PLS) approach to generalized inverses. SIAM J Sci Stat Comput 5:735-743
33. Wold S, Albano C, Dunn W, Edlund U, Esbensen K, Geladi P, Hellberg S, Johansson E, Lindberg W, Sjostrom M (1987) Multivariate data analysis in chemistry. In: B. Kowalski (ed) Chemometrics: mathematics and statics in chemistry. Reidel, Dordrecht, p 17